Vogloyd 3D 2.2 Forte 2mg/1000mg/0.2mg Tablet SR
By Vogloyd 3D
Rx
15 Tablet SR in a Strip

Composition
Glimepiride(2mg) + Metformin(1000mg) + Voglibose(0.2mg)

Manufacturer - Lloyd Healthcare Pvt Ltd
702, Balaji Business Park, Andheri Kurla Road, Marol Naka, Andheri East, Gamdevi, Marol, Andheri East, Mumbai, Maharashtra 400059

Expires on or after
June, 2026

liver
Caution should be taken when using Vogloyd 3D 2.2 Forte 2mg/1000mg/0.2mg Tablet SR in patients with liver disease. It may be necessary to adjust the dose of the medication in such cases. Your doctor should be consulted before starting this medication. Typically, Vogloyd 3D 2.2 Forte 2mg/1000mg/0.2mg Tablet SR is initially prescribed at a low dose for patients with mild to moderate liver disease. However, it is not advisable to use this medication in individuals with severe liver disease.

kidney
Vogloyd 3D 2.2 Forte 2mg/1000mg/0.2mg Tablet SR is not safe for use in patients with kidney disease and should be avoided. Consult your doctor before using, especially if you have severe kidney issues.

alcohol
It is not safe to drink alcohol while taking Vogloyd 3D 2.2 Forte 2mg/1000mg/0.2mg Tablet SR. Consulting your doctor is recommended.

driving
For safe driving, avoid driving if experiencing low or high blood sugar symptoms while taking Vogloyd 3D 2.2 Forte 2mg/1000mg/0.2mg Tablet SR. It may impact focus and reaction time.

pregnancy
Vogloyd 3D 2.2 Forte 2mg/1000mg/0.2mg Tablet SR may not be safe during pregnancy. Animal studies suggest potential harm to the developing baby. Your doctor will evaluate the risks and benefits before prescribing. Please consult your doctor before use.

breastfeeding
Caution should be taken while breastfeeding if considering Vogloyd 3D 2.2 Forte 2mg/1000mg/0.2mg Tablet SR. Limited data suggests it may pass into breastmilk and potentially harm the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
₹251.9
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024